Kristin Rand joined Lykos Therapeutics as chief compliance officer in February of 2024 and assumed the role of interim general counsel in July of 2024. She is an experienced corporate compliance, enterprise risk and legal professional with decades of experience managing business risk. Kristin most recently developed and oversaw the corporate compliance and enterprise risk programs as chief compliance officer and head of risk for National Resilience Inc. and Moderna. Over her 20 plus years in the biopharma industry Kristin also held various leadership roles in medical affairs, compliance and legal for Wyeth, Genentech and Seattle Genetics (“SeaGen”). Kristin earned her Bachelor of Diagnostic Genetic Sciences from the University of Connecticut, an M.A. in Industrial-Organizational Psychology from Northcentral University, and her Juris Doctorate from Quinnipiac University School of Law. She is a member of the Connecticut Bar.